Surveillance
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project

https://doi.org/10.1016/j.diagmicrobio.2004.10.009Get rights and content

Abstract

The Alexander Project is a global surveillance study conducted from 1992 to 2001. Minimum inhibitory concentrations and percent resistance to a panel of antimicrobial agents were determined according to National Committee for Clinical Laboratory Standards methodology. Resistance to penicillin (PEN-R) and erythromycin (ERY-R) have increased in the period 1992–2001 by 3.9 and 4.5 times to 20.7% and 27.9%, respectively. Joint PEN–ERY-R has increased 4.9 times, up to 15.3%. In 1992, 57.1% of all PEN-R isolates were also ERY-R, whereas in 2001, 75.8% were ERY-R. Resistance to only 1 antibiotic increased slightly, from 8% in 1992 to 12% in 2001, whereas resistance to more than 1 antibiotic increased 4.3 times, from 6.4% in 1992 to 27.8% of all strains in 2001. Multidrug-resistant pneumococci are an increasingly common finding in the United States. Three of four PEN-R isolates are also multiresistant. The rate of growth of multidrug resistance is higher than that of single antibiotic resistance.

Introduction

Streptococcus pneumoniae continues to be a major cause of morbidity and mortality worldwide (Baquero, 1995, Smith and Coast, 2002). The organism remains the leading bacterial cause of community-acquired pneumonia, otitis media, and sinusitis (McDougal et al, 1992). Because identity and antimicrobial susceptibility results are rarely available to the clinician in an outpatient setting at the time the patient is seen, antibiotic therapy is often empiric. Strains that have a high level of resistance to penicillin (PEN-R) and other antimicrobial agents appeared in the United States at a low prevalence in the early 1990s (Breiman et al, 1994), having been first reported by researchers in Boston in 1965, and subsequently in Australia in 1967 and South Africa in 1977 (Appelbaum, 1992). Within the past few years, increasing numbers of resistant and multiple resistant (Appelbaum, 1992) isolates of S. pneumoniae have become a worldwide problem (Felmingham, 1999). The emergence of double and triple antimicrobial resistance is a matter of major concern (Smith and Coast, 2002). Treatment failures due to drug resistance have been reported with meningitis (Sloas et al., 1992, Catalan et al., 1994), otitis media (Jacobs, 1996), and community acquired pneumonia (Garau, 2001). Multiresistance and the potential spread of these organisms have crucial implications for the treatment and clinical outcome of patients.

Established in 1992, the Alexander Project is an international surveillance study examining the antimicrobial susceptibility of the major upper and lower respiratory tract bacterial pathogens and identifying trends in the development of resistance over time. Antimicrobial susceptibility is established to a range of compounds, with testing undertaken in 3 central laboratories using standardized procedures (Felmingham et al, 1996). The current analysis comprises US antimicrobial susceptibility data for 1992–2001 for S. pneumoniae and describes the emergence of penicillin, macrolide, and multidrug resistance among pneumococcal strains isolated from patients with community-acquired respiratory tract infections in several regions of the United States. This data collection provides a unique source to analyze trends in resistance over a 10-year period.

Section snippets

Methods

Five centers in different regions of the United States participated during the period 1992–1998; 30 centers in 23 states were included in 1998, 16 centers in 11 states in 1999, and 23 centers in 20 states in 2000–2001. The states and years can be seen in Fig. 1.

Inclusion criteria for bacterial isolates, transportation and storage, reidentification, and susceptibility testing methods have been described in detail previously (Grüneberg and Felmingham, 1996). Briefly, strains isolated from upper

Results

A total of 3721 S. pneumoniae isolates were collected in the United States during the period 1992–2001. Age, sex, and isolate source distributions are available since 1998. Of all the isolates, 55% came from men and 45% from women. The average age of the patients was 54 ± 19 years old (range 13–103 years). The distribution by source in 2001 is as follows: 62.6% from sputum, 28.4% from blood, 6.3% from the nasopharynx, and 2.7% from other various sources.

PEN-R (MIC ≥ 2 μg/mL) was 5.6% in 1992

Discussion

This study reveals the development of antibiotic resistance of S. pneumoniae in the United States over a 10-year period (1992–2001). Resistance increased from initially low levels in 1992 to reach a plateau from 1998 onward, decreasing slightly in 2000 and in 2001. The PEN-R and ERY-R levels are not dissimilar to the SENTRY Antimicrobial Surveillance Program (Jones et al, 2003). Regional trends for 1999–2000 are also in line with observations from the TRUST surveillance program (Thornsberry et

References (24)

  • D. Felmingham

    Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens—Findings from the Alexander Project 1992–1996

    J. Chemother.

    (1999)
  • G. Doern

    Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States

    Clin. Infect. Dis.

    (2001)
  • Cited by (67)

    • Professional practice evaluation of emergency department prescriptions for community-acquired infections in Lebanon

      2017, International Journal of Infectious Diseases
      Citation Excerpt :

      Selecting an appropriate antibiotic regimen for patients with bacterial infections has an important role in improving patient outcomes, minimizing antimicrobial resistance, and consequently reducing costs (Paterson, 2006; Standiford et al., 2012). Several studies have shown that in many cases antibiotics are prescribed without a justified indication (Mera et al., 2005; Donnelly et al., 2014; Xu et al., 2013). Some studies have reported a rate of inappropriate antibiotic use of up to 43% (Xu et al., 2013; Hecker et al., 2003; O’Brien et al., 2015).

    • Comparison of transformation frequencies among selected Streptococcus pneumoniae serotypes

      2010, International Journal of Antimicrobial Agents
      Citation Excerpt :

      In sub-Saharan Africa, pneumococci are a significant cause of morbidity and mortality because of limited access to adequate health care and the high prevalence of HIV infection [5]. The number of reported antibiotic-resistant clinical isolates of S. pneumoniae has increased markedly over the last 30 years, and multidrug-resistant (MDR) strains have emerged [6–9]. The global emergence and spread of antimicrobial resistance in S. pneumoniae is a serious concern [9,10].

    View all citing articles on Scopus

    Parts of this manuscript were presented as a poster to the 2003 IDSA Meeting in San Diego.

    View full text